After the benchmark S&P/ASX 200 surged 7.5 per cent in 2024, investors are looking to see where the growth will come from in ...

The advent of a Trump presidency is accelerating a divergence on digital currencies between the world’s two largest economies ...

Cell therapies have suffered from hyped-up expectations, clinical setbacks and high costs. But maybe, just maybe, Arovella is ...

Riversgold’s (ASX:RGL) rock chip sampling is defining multiple multi-metal targets across the ~25 km strike of the Saint John ...

ASX climbs while Bitcoin surges past US$102k thanks to Trump’s crypto push and Capricorn hits a gold output record.

Special Report: James Bay Minerals is progressing exploration at its Independence gold project in Lander County, Nevada, with ...

Kalamazoo Resources led materials sector gainers this morning as the release of drill assays from its Mallina West gold ...

Opyl has entered a joint venture with X Firm to market its TrialKey platform in key markets, while Dimerix has inked another ...

Neurizon recently received EMA orphan designation for NUZ-001 to treat ALS and filed an FDA IND application to begin a phase ...

Fraser Palamara details Dimerix's (ASX:DXB) deal with Japanese pharmaceutical company FUSO to fight a deadly kidney disease.

ASX tech rocked a 50pc gain in 2024, Archer Materials shone in December, and Dubber and Brainchip have cashed in on major ...

Gold outshined the chasing pack as only a handful of commodities sailed through choppy economic waters unscathed in a ...